Arcutis Biotherapeutics, Inc. ( ARQT) - Stock Earnings
ARQT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026, midnight | — / — | — | — / — | — |
ARQT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 17.4 million USD | 129.5 million USD |
| 2026Q1 | -11.3 million USD | 105.4 million USD |
| 2026Q2 | 15.0 million USD | 129.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ARQT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -262.1 million USD | 59.6 million USD |
| 2024 | -140.0 million USD | 196.5 million USD |
| 2025 | -16.1 million USD | 376.1 million USD |
| 2026 Est. | — | — |
ARQT
Price: $29.10
Earnings Per Share: 0.22 USD
P/E Ratio: 119.23
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 827862
Market Capitalization: 3.1 billion